Hiroshi Ishii

26PUBLICATIONS
26CO-AUTHORS
Medical bacteriologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Medical molecular engineering of nucleic acids and proteinsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jun 25, 2026
Clinical Outcomes of Metronidazole Monotherapy Versus Metronidazole Plus Clostridium butyricum MIYAIRI 588 Combination Therapy in Non-Severe Clostridioides difficile Infection: A Retrospective Cohort Study.

|Feb 18, 2026
Upfront combination therapy with nintedanib and anti-inflammatory agents for progressive pulmonary fibrosis: a multicentre, single-arm phase 2 study (TOP-ILD).

Kazuya Tsubouchi, Masayuki Hirose, Reoto Takei

|Sep 01, 2025
Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis.

Kazuya Tsubouchi, Toyoshi Yanagihara, Fumiaki Kiyomi

|Jul 30, 2025
Adrenomedullin Therapy for Moderate-to-Severe COVID-19 Pneumonia: Double-Blind Placebo-Controlled Phase 2a Trial.

Toshihiro Kita, Norio Ohmagari, Sho Saito

|May 01, 2025
A Fragmented Rib as the First Clue to Advanced Lung Adenocarcinoma.

Hiroshi Ishii, Takuhide Utsunomiya, Yoshiaki Kinoshita

|Apr 28, 2025
Idiopathic pleuroparenchymal fibroelastosis: diagnosis and management.

Hiroshi Ishii, Yoshiaki Kinoshita, Naoki Hamada

Pageof 5

Frequent Collaborators

7 joint publications

Yoshiaki Kinoshita

5 joint publications

Motoyasu Miyazaki

2 joint publications

Kazuhiro Yatera

2 joint publications

Isamu Okamoto